1,143
Views
12
CrossRef citations to date
0
Altmetric
Articles

A Gratuitous Grace: The Influence of Religious Set and Intent on the Psychedelic Experience

, B.Sc., & , Ph.D.
Pages 314-321 | Received 31 Jul 2017, Accepted 23 May 2018, Published online: 27 Jul 2018

References

  • Allegro, J. M. 1973. The sacred mushroom and the cross: A study of the nature and origins of christianity within the fertility cults of the ancient near East. London: Sphere Books.
  • Alper, K. R., H. S. Lotsof, and C. D. Kaplan. 2008. The ibogaine medical subculture. Journal of Ethnopharmacology 115(1):9–24. doi:10.1016/j.jep.2007.08.034.
  • Baker, J. R. 2005. Psychedelic sacraments. Journal of Psychoactive Drugs 37(2):179–87. doi:10.1080/02791072.2005.10399799.
  • Becker, H. S. 1967. History, culture and subjective experience: An exploration of the social bases of drug-induced experiences. Journal of Health and Social Behavior 8(3):163–76.
  • Bogenschutz, M., A. Forcehimes, J. Pommy, C. Wilcox, P. C. R. Barbosa, and R. Strassman. 2015. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology 29(3):289–99. doi:10.1177/0269881114565144.
  • De Rios, M. D. 2005. Psychedelic drugs. Encyclopedia of Religion 11:7467–73.
  • Doblin, R. 1991. Pahnke’s ‘Good Friday Experiment’: A long term follow-up and methodological critique. The Journal of Transpersonal Psychology 23(1):1–28.
  • Gasser, P., K. Kirchner, and T. Passie. 2015. LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology 29(1):57–68. doi:10.1177/0269881114555249.
  • Griffiths, R. R., W. A. Richards, M. W. Johnson, U. D. McCann, and R. Jesse. 2008. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology 22(6):621–32. doi:10.1177/0269881108094300.
  • Griffiths, R. R., W. A. Richards, U. McCann, and R. Jesse. 2006. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology 187(3):268–83. doi:10.1007/s00213-006-0457-5.
  • Hood, R. W. 1975. The construction and preliminary validation of a measure of reported mystical experience. Journal for the Scientific Study of Religion 14(1):29–41. doi:10.2307/1384454.
  • Hood, R. W., Jr., N. Ghorbani, P. J. Watson, A. F. Ghramaleki, M. N. Bing, H. K. Davison, R. J. Morris, and W. P. Williamson. 2001. Dimensions of the Mysticism Scale: Confirming the Three-Factor Structure in the United States and Iran. Journal for the Scientific Study of Religion 40(4):691–705. doi:10.1111/0021-8294.00085.
  • Johansen, P., and T. S. Krebs. 2015. Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology 29(3):270–79. doi:10.1177/0269881114568039.
  • Johnson, M., A. Garcia-Romeu, M. Cosimano, and R. Griffiths. 2014. Pilot study of the 5-HT2AR Agonist Psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology 28(11):983–92. doi:10.1177/0269881114548296.
  • Kavenská, V., and H. Simonová. 2015. Ayahuasca tourism: Participants in shamanic rituals and their personality styles, motivation, benefits and risks. Journal of Psychoactive Drugs 47(5):351–59. doi:10.1080/02791072.2015.1094590.
  • Kjellgren, A., and T. Norlander. 2000. Psychedelic drugs: A study of drug-induced experiences obtained by illegal drug users in relation to Stanislav Grof’s model of altered states of consciousness. Imagination, Cognition and Personality 20(1):41–57. doi:10.2190/A2RX-XV10-NHUE-3612.
  • Krebs, T. S., and P. Johansen. 2012. Lysergic Acid Diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Journal of Psychopharmacology 26(7):994–1002. doi:10.1177/0269881112439253.
  • Labate, B. C., I. S. Rose, and R. G. dos Santos. 2009. Ayahuasca religions: A comprehensive bibliography and critical essays. Santa Cruz: Multidisciplinary Association for Psychedelic Studies.
  • Leary, T., R. Metzner, and R. Alpert. 1964. The psychedelic experience: A manual based on the Tibetan Book of the dead. New York: University Books.
  • Lerner, M., and M. Lyvers. 2006. Values and beliefs of psychedelic drug users: A cross-cultural study. Journal of Psychoactive Drugs 38(2):143–47. doi:10.1080/02791072.2006.10399838.
  • Maclean, K. A., M. W. Johnson, and R. R. Griffiths. 2011. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology 25(11):1453–61. doi:10.1177/0269881111420188.
  • Miller, R. J. 2015. Drugged: The science and culture behind psychotropic drugs. New York: Oxford University Press.
  • Mithoefer, M. C., M. T. Wagner, A. T. Mithoefer, L. Jerome, and R. Doblin. 2011. The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology 25(4):439–52. doi:10.1177/0269881110378371.
  • Móró, L., K. Simon, I. Bárd, and J. Rácz. 2011. Voice of the psychonauts: Coping, life purpose, and spirituality in psychedelic drug users. Journal of Psychoactive Drugs 43(3):188–98. doi:10.1080/02791072.2011.605661.
  • Orsolini, L., G. D. Papanti, G. Francesconi, and F. Schifano. 2015. Mind navigators of chemicals’ experimenters? A web-based description of E-psychonauts. Cyberpsychology, Behavior and Social Networking 18(5):296–300. doi:10.1089/cyber.2014.0486.
  • Osório, F. D. L., R. F. Sanches, L. R. Macedo, R. G. dos Santos, J. P. Maia-de-Oliveira, L. Wichert-Ana, D. B. de Araujo, J. Riba, J. A. Crippa, and J. E. Hallak. 2015. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A preliminary report. Revista Brasileira De Psiquiatria 37(1):13–20. doi:10.1590/1516-4446-2014-1496.
  • Pahnke, W. N. 1966. Drugs and mysticism. The International Journal of Parapsychology 8(2):295–313.
  • Shanon, B. 2008. Biblical Entheogens: a Speculative Hypothesis. Time and Mind 1(1):51–74. doi:10.2752/175169608783489116
  • Smith, D. E., G. E. Raswyck, and L. D. Davidson. 2014. From Hofmann to the Haight Ashbury, and into the future: The past and potential of lysergic acid diethlyamide. Journal of Psychoactive Drugs 46(1):3–10. doi:10.1080/02791072.2014.87368
  • Smith, H. 1964. Do drugs have religious import? The Journal of Philosophy 61(18):517–30. doi:10.2307/2023494.
  • Trichter, S., J. Klimo, and S. Krippner. 2009. Changes in spirituality among ayahuasca ceremony novice participants. Journal of Psychoactive Drugs 41(2):121–34. doi:10.1080/02791072.2009.10399905.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.